It has been estimated that the human immune system can produce up to 1 quintillion different antibodies by changing the sequence of these amino acids, helping to ensure that the body can respond ...

Quantum-Si aims to revolutionize protein sequencing amidst technological hurdles, uncertain advancements, and market ...

“Integrated with single cell sequencing technology, the target antibody sequences can be easily obtained. This reduces the cycle of the whole process, from defining the target to generating ...

Our immune system works to fight infections immediately, but also maintain long-term immunity. Two waves of protection help neutralize and eliminate diseas | Immunology ...

A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a ...

The sequence homology is over 95%; PTM and aggregation prediction reports are also available 100% success rate As quick as 3–4 weeks to offer required humanized antibodies Affinity evaluated by ...

The impacts of next-generation sequencing (NGS) can be seen throughout multiple phases of therapeutic antibody development, from discovery and engineering to manufacturing. Sequencing is a ...

De novo antibody design has been one of the major challenges in AI-based drug discovery, requiring atomic-level precision to ...

The resulting antibodies are maximally de-risked with respect to immunogenicity, because every V region sequence has been expressed in a human body before. This, in combination with the early de ...

Harbour BioMed, a global biopharmaceutical company committed to the discovery, development, and commercialization of novel ...

antibody sequencing; and assay development. Further, it offers a profiling toolset for antibody lead candidates; and in vitro analytical tools for the study of quality attributes. Additionally ...

SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...